Nifty
:
22620.40
Sensex
:
74398.48
50.05 (0.22%)
59.04 (0.08%)
Nifty
Sensex
:
:
22620.40
74398.48
50.05 (0.22%)
59.04 (0.08%)

Alpa Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
52/99

BSE: 532878 | NSE: ALPA

NSE BSE
96.60
25-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  96.05
  •  98.00
  •  95.90
  •  95.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  43798
  •  42.37
  •  115.00
  •  55.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 201.46
  • 11.20
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 200.61
  • N/A
  • 1.36

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.29%
  • 1.49%
  • 36.84%
  • FII
  • DII
  • Others
  • 0.5%
  • 0.00%
  • 3.88%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.07
  • 3.57
  • -1.59

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.62
  • 47.69
  • 0.99

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 65.60
  • 20.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.07
  • 14.44
  • 11.92

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.84
  • 0.91
  • 1.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.51
  • 7.78
  • 8.58

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
27.31
27.31
0.00%
32.39
13.54
139.22%
25.43
22.42
13.43%
29.16
25.16
15.90%
Expenses
24.88
24.69
0.77%
29.04
19.24
50.94%
26.57
20.96
26.77%
19.95
24.27
-17.80%
EBITDA
2.43
2.62
-7.25%
3.35
-5.69
-
-1.14
1.46
-
9.21
0.89
934.83%
EBIDTM
8.91%
9.61%
10.35%
-42.03%
-4.49%
6.51%
31.58%
3.55%
Other Income
3.53
2.67
32.21%
2.95
6.33
-53.40%
4.44
1.61
175.78%
-0.69
1.64
-
Interest
0.02
0.07
-71.43%
0.02
0.08
-75.00%
0.02
0.03
-33.33%
0.03
0.05
-40.00%
Depreciation
0.66
0.10
560.00%
0.49
0.36
36.11%
0.28
0.34
-17.65%
0.53
0.50
6.00%
PBT
5.30
5.12
3.52%
5.79
0.20
2,795.00%
3.03
2.70
12.22%
7.96
1.98
302.02%
Tax
0.79
0.00
0
0.00
0.00
0
0.00
0.00
0
3.31
5.47
-39.49%
PAT
4.51
5.12
-11.91%
5.79
0.20
2,795.00%
3.03
2.70
12.22%
4.65
-3.49
-
PATM
16.52%
18.74%
17.87%
1.50%
11.92%
12.06%
15.94%
-13.87%
EPS
2.14
2.43
-11.93%
2.75
0.10
2,650.00%
1.44
1.28
12.50%
2.21
-1.66
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
114.29
92.96
112.27
97.55
85.97
77.99
62.85
63.45
53.59
57.39
56.71
Net Sales Growth
29.24%
-17.20%
15.09%
13.47%
10.23%
24.09%
-0.95%
18.40%
-6.62%
1.20%
 
Cost Of Goods Sold
70.03
54.94
69.77
59.47
51.00
48.83
36.24
36.32
27.88
36.10
32.10
Gross Profit
44.26
38.01
42.49
38.09
34.97
29.16
26.61
27.13
25.71
21.30
24.61
GP Margin
38.73%
40.89%
37.85%
39.05%
40.68%
37.39%
42.34%
42.76%
47.98%
37.11%
43.40%
Total Expenditure
100.44
84.88
101.61
89.86
82.61
76.84
58.92
56.34
47.33
54.66
51.05
Power & Fuel Cost
-
3.04
2.64
2.43
2.21
2.01
1.76
1.58
1.49
1.80
2.42
% Of Sales
-
3.27%
2.35%
2.49%
2.57%
2.58%
2.80%
2.49%
2.78%
3.14%
4.27%
Employee Cost
-
12.17
11.93
11.75
11.82
12.04
10.26
8.67
7.20
7.63
7.97
% Of Sales
-
13.09%
10.63%
12.05%
13.75%
15.44%
16.32%
13.66%
13.44%
13.29%
14.05%
Manufacturing Exp.
-
3.52
3.67
2.86
2.07
2.24
1.81
1.72
1.35
2.11
2.12
% Of Sales
-
3.79%
3.27%
2.93%
2.41%
2.87%
2.88%
2.71%
2.52%
3.68%
3.74%
General & Admin Exp.
-
2.07
3.45
3.05
3.45
3.20
2.20
3.02
3.84
3.30
2.69
% Of Sales
-
2.23%
3.07%
3.13%
4.01%
4.10%
3.50%
4.76%
7.17%
5.75%
4.74%
Selling & Distn. Exp.
-
5.16
5.79
4.49
5.34
5.00
4.12
3.04
2.73
2.54
2.85
% Of Sales
-
5.55%
5.16%
4.60%
6.21%
6.41%
6.56%
4.79%
5.09%
4.43%
5.03%
Miscellaneous Exp.
-
3.97
4.35
5.82
6.73
3.51
2.53
1.99
2.84
1.19
2.85
% Of Sales
-
4.27%
3.87%
5.97%
7.83%
4.50%
4.03%
3.14%
5.30%
2.07%
1.57%
EBITDA
13.85
8.08
10.66
7.69
3.36
1.15
3.93
7.11
6.26
2.73
5.66
EBITDA Margin
12.12%
8.69%
9.49%
7.88%
3.91%
1.47%
6.25%
11.21%
11.68%
4.76%
9.98%
Other Income
10.23
9.37
10.78
4.40
2.91
5.30
4.86
5.14
5.75
3.47
0.57
Interest
0.09
0.22
0.22
0.08
0.20
0.57
1.07
1.71
1.45
1.70
2.12
Depreciation
1.96
1.33
1.66
1.23
3.16
3.12
3.07
2.78
0.83
6.07
9.06
PBT
22.08
15.89
19.56
10.79
2.91
2.76
4.64
7.75
9.74
-1.56
-4.95
Tax
4.10
3.31
5.47
3.54
1.05
1.74
1.83
3.12
2.89
-1.31
0.20
Tax Rate
18.57%
20.83%
27.97%
32.81%
36.08%
63.04%
39.44%
55.42%
29.67%
48.34%
-4.04%
PAT
17.98
12.58
14.09
7.25
1.85
1.01
2.81
2.52
6.85
-1.40
-5.15
PAT before Minority Interest
17.98
12.58
14.09
7.25
1.85
1.01
2.81
2.52
6.85
-1.40
-5.15
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
15.73%
13.53%
12.55%
7.43%
2.15%
1.30%
4.47%
3.97%
12.78%
-2.44%
-9.08%
PAT Growth
296.91%
-10.72%
94.34%
291.89%
83.17%
-64.06%
11.51%
-63.21%
-
-
 
EPS
8.56
5.99
6.71
3.45
0.88
0.48
1.34
1.20
3.26
-0.67
-2.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
134.58
121.73
107.64
100.37
98.49
97.55
94.73
93.41
86.56
88.31
Share Capital
21.04
21.04
21.04
21.04
21.04
21.04
21.04
21.04
21.04
21.04
Total Reserves
113.54
100.69
86.60
79.33
77.45
76.51
73.69
72.36
65.52
67.27
Non-Current Liabilities
3.06
4.70
0.23
-0.73
0.24
-0.15
0.44
0.55
0.41
6.11
Secured Loans
0.78
2.12
0.01
0.19
0.41
0.61
0.47
0.00
0.00
4.20
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
29.63
28.81
32.50
20.79
22.31
23.36
29.71
52.40
41.24
32.30
Trade Payables
15.06
14.92
24.73
13.70
13.19
13.27
13.94
18.62
9.03
10.62
Other Current Liabilities
10.89
8.90
5.80
4.11
5.83
3.84
4.08
4.91
2.39
4.89
Short Term Borrowings
0.00
2.34
0.00
0.00
1.05
5.18
10.16
24.23
28.57
16.05
Short Term Provisions
3.68
2.65
1.97
2.97
2.24
1.07
1.53
4.64
1.26
0.74
Total Liabilities
167.27
155.24
140.37
120.43
121.04
120.76
124.88
146.36
128.21
126.72
Net Block
7.04
9.32
7.21
6.42
7.78
10.17
11.25
14.64
4.80
73.11
Gross Block
33.46
34.41
30.64
40.12
38.85
38.12
36.15
34.74
24.06
102.01
Accumulated Depreciation
26.42
25.09
23.43
33.71
31.07
27.96
24.90
20.10
19.27
28.90
Non Current Assets
18.14
17.23
19.28
24.96
26.96
23.04
20.23
27.49
15.59
73.95
Capital Work in Progress
0.00
0.00
1.57
0.81
0.12
0.00
0.00
0.00
0.07
0.00
Non Current Investment
6.43
5.93
10.15
17.29
18.63
12.88
8.98
12.16
10.10
0.00
Long Term Loans & Adv.
1.45
0.22
0.23
0.24
0.13
0.00
0.00
0.69
0.62
0.84
Other Non Current Assets
3.23
1.76
0.11
0.20
0.30
0.00
0.00
0.00
0.00
0.00
Current Assets
149.13
138.01
121.09
95.46
94.09
97.72
104.65
118.87
112.63
52.76
Current Investments
72.03
68.70
40.69
39.30
29.96
17.68
7.93
0.00
0.00
0.00
Inventories
12.64
15.46
16.56
12.55
14.04
13.72
13.04
15.00
7.52
13.00
Sundry Debtors
46.73
38.04
35.43
24.59
30.00
26.02
29.16
34.34
24.48
20.08
Cash & Bank
8.81
1.58
10.51
6.17
0.90
21.34
36.68
36.64
72.14
10.46
Other Current Assets
8.92
4.74
2.40
1.28
19.19
18.95
17.84
32.88
8.49
9.21
Short Term Loans & Adv.
5.83
9.50
15.50
11.58
17.55
17.52
16.29
22.15
6.90
8.34
Net Current Assets
119.50
109.20
88.59
74.68
71.77
74.36
74.94
66.47
71.38
20.46
Total Assets
167.27
155.24
140.37
120.42
121.05
120.76
124.88
146.36
128.22
126.71

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
8.90
9.94
-1.70
17.78
-1.00
-12.70
16.99
-21.85
-1.84
8.06
PBT
15.68
19.56
10.78
2.91
2.76
4.64
5.63
9.74
-2.71
-4.95
Adjustment
-2.38
-7.96
0.73
5.88
0.79
0.82
0.61
-0.21
6.19
11.73
Changes in Working Capital
-0.80
1.45
-10.35
10.15
-2.39
-16.33
13.85
-28.49
-6.63
1.49
Cash after chg. in Working capital
12.50
13.06
1.16
18.94
1.16
-10.87
20.09
-18.96
-3.15
8.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.60
-3.12
-2.86
-1.16
-2.17
-1.83
-3.10
-2.89
1.31
-0.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
2.13
-15.61
5.86
-11.16
-14.66
-11.46
-1.71
-8.03
37.43
-2.19
Net Fixed Assets
0.95
-2.20
-1.39
-1.95
-0.86
-1.97
-1.42
-0.49
77.88
Net Investments
-3.87
-23.80
5.68
-8.18
-18.09
-17.85
-1.36
-12.02
-10.11
Others
5.05
10.39
1.57
-1.03
4.29
8.36
1.07
4.48
-30.34
Cash from Financing Activity
-3.79
5.44
0.18
-1.35
-4.78
8.83
-15.23
-5.62
6.82
3.92
Net Cash Inflow / Outflow
7.24
-0.23
4.34
5.27
-20.44
-15.33
0.05
-35.50
42.42
9.79
Opening Cash & Equivalents
1.58
1.80
6.17
0.90
21.34
36.68
36.63
52.74
10.32
0.53
Closing Cash & Equivalent
8.81
1.58
10.51
6.17
0.90
21.35
36.68
17.24
52.74
10.32

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
63.96
57.86
51.16
47.70
46.81
46.36
45.02
44.39
41.14
41.97
ROA
7.80%
9.53%
5.56%
1.54%
0.84%
2.29%
1.86%
4.99%
-1.10%
-4.07%
ROE
9.82%
12.29%
6.97%
1.86%
1.03%
2.92%
2.68%
7.61%
-1.60%
-5.84%
ROCE
12.19%
16.81%
10.42%
3.09%
3.26%
5.47%
6.59%
9.61%
-0.89%
-2.54%
Fixed Asset Turnover
2.74
3.45
2.76
2.18
2.03
1.69
1.79
1.96
0.98
0.59
Receivable days
166.43
119.43
112.28
115.88
131.09
160.24
182.65
186.53
131.56
121.24
Inventory Days
55.18
52.06
54.46
56.45
64.97
77.71
80.64
71.40
60.59
78.52
Payable days
99.58
103.71
117.94
64.11
67.42
88.04
111.78
111.89
64.48
67.60
Cash Conversion Cycle
122.02
67.77
48.80
108.22
128.63
149.91
151.51
146.05
127.67
132.16
Total Debt/Equity
0.02
0.05
0.00
0.00
0.02
0.06
0.11
0.26
0.33
0.26
Interest Cover
72.07
90.32
139.47
15.82
5.85
5.33
4.30
7.73
-0.59
-1.33

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Alpa Lab - Quarterly Results
    13th Feb 2024, 18:49 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.